Evidence map›Paper›PMID 30139804›Full record

ArticleClinical journal of the American Society of Nephrology : CJASN2018

Clinical and Economic Benefits of Antimicrobial Stewardship Programs in Hemodialysis Facilities: A Decision Analytic Model.

Erika M C D'Agata, Diana Tran, Josef Bautista, Douglas Shemin, Daniel Grima

Open access · bronzeAbstract read
In one paragraph

Article in Clinical journal of the American Society of Nephrology : CJASN, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed, 1 pooled it
1.2field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 1 synthesis or guideline pooled it, 29 citations in OpenAlex.

  1. Pooled it
  2. Observational
  3. Article
  4. Review
  5. Patterns of Antimicrobial Use in an Outpatient Hemodialysis Unit.The Canadian journal of hospital pharmacy · 2022
    Article
  6. Article
  7. Article
  8. Article
  9. Potential influence of rapid diagnostics on timeliness of management decisions for patients with positive blood cultures.Journal of the Association of Medical Microbiology and Infectious Disease Canada = Journal officiel de l'Association pour la microbiologie medicale et l'infectiologie Canada · 2020
    Article
  10. Antimicrobial resistance in nephrology.Nature reviews. Nephrology · 2019
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 3 institutions in 1 country.

Erika M C D'AgataDivisions of Infectious Diseases and.
Diana TranCornerstone Research Group, Burlington, Ontario, Canada; and.
Josef BautistaHypertension and Nephrology Inc., Providence, Rhode Island.
Douglas SheminNephrology, Rhode Island Hospital, Brown University, Providence, Rhode Island.
Daniel GrimaCornerstone Research Group, Burlington, Ontario, Canada; and.
Office of Infectious Diseases · USProvidence College · USRhode Island Hospital · US

Funding

Antimicrobial Use in Dialysis UnitsR18HS021666 · AHRQ · RHODE ISLAND HOSPITAL · PI D'AGATA, ERIKA M · 2013 to 2015
$1.4M
Midcareer Investigator Award in Patient-Oriented ResearchK24AI119158 · NIAID · RHODE ISLAND HOSPITAL · PI D'AGATA, ERIKA M · 2016 to 2020
$885k
AHRQ HHS R18 HS021666NIAID NIH HHS K24 AI119158
6 · The paper itself

Abstract

BACKGROUND AND

objectivesInfections caused by multidrug-resistant organisms and DESIGN, SETTING, PARTICIPANTS, & MEASUREMENTS: We developed a decision analytic model of antimicrobial use on the clinical and economic consequences of implementing a nationwide antimicrobial stewardship program in outpatient dialysis facilities. The main outcomes were total antimicrobial use, infections caused by multidrug-resistant organisms and

resultsOn a national level, implementation of antimicrobial stewardship programs was predicted to result in 2182 fewer infections caused by multidrug-resistant organisms and

conclusionsThe model suggests that implementation of antimicrobial stewardship programs in outpatient dialysis facilities would result in substantial reductions in infections caused by multidrug-resistant organisms and

Indexed as

Decision Support TechniquesHealth Care CostsRenal DialysisAmbulatory Care FacilitiesAnti-Bacterial AgentsAntimicrobial StewardshipClostridium InfectionsCost ControlDecision TreesDrug Resistance, Multiple, BacterialHumansAnti-Bacterial AgentsAnti-Bacterial AgentsAnti-Infective AgentsAntimicrobial Stewardshipcefazolinchronic hemodialysisClostridium difficileClostridium InfectionscostsCost SavingsEnterococcusHealth Care Costsinfectionsmaintenance hemodialysismortalitymultidrug-resistant organismsOutpatientsProbabilityrenal dialysisvancomycin

Identifiers

PMID30139804
PMCPMC6140563
OpenAlexW2888096961

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.